| Non-small cell lung cancer: current treatment and future advances C Zappa, SA Mousa Translational lung cancer research 5 (3), 288, 2016 | 2072 | 2016 |
| Omega-3 fatty acids EPA and DHA: health benefits throughout life D Swanson, R Block, SA Mousa Advances in nutrition 3 (1), 1-7, 2012 | 1923 | 2012 |
| Regulation of angiogenesis in vivo by ligation of integrin α5β1 with the central cell-binding domain of fibronectin S Kim, K Bell, SA Mousa, JA Varner The American journal of pathology 156 (4), 1345-1362, 2000 | 864 | 2000 |
| International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer D Farge, P Debourdeau, M Beckers, C Baglin, RM Bauersachs, B Brenner, ... Journal of Thrombosis and Haemostasis 11 (1), 56-70, 2013 | 709 | 2013 |
| Integrin αVβ3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis JJ Bergh, HY Lin, L Lansing, SN Mohamed, FB Davis, S Mousa, PJ Davis Endocrinology 146 (7), 2864-2871, 2005 | 703 | 2005 |
| The role of angiogenesis in cancer treatment M Rajabi, SA Mousa Biomedicines 5 (2), 34, 2017 | 683 | 2017 |
| Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer Z Chen, PS Malhotra, GR Thomas, FG Ondrey, DC Duffey, CW Smith, ... Clinical cancer research 5 (6), 1369-1379, 1999 | 622 | 1999 |
| Biosensors: the new wave in cancer diagnosis B Bohunicky, SA Mousa Nanotechnology, science and applications, 1-10, 2010 | 562 | 2010 |
| Emerging nanopharmaceuticals WE Bawarski, E Chidlowsky, DJ Bharali, SA Mousa Nanomedicine: Nanotechnology, Biology and Medicine 4 (4), 273-282, 2008 | 542 | 2008 |
| Chemoenzymatic synthesis of homogeneous ultralow molecular weight heparins Y Xu, S Masuko, M Takieddin, H Xu, R Liu, J Jing, SA Mousa, RJ Linhardt, ... Science 334 (6055), 498-501, 2011 | 471 | 2011 |
| Apoptosis and acute brain ischemia in ischemic stroke D Radak, N Katsiki, I Resanovic, A Jovanovic, E Sudar-Milovanovic, ... Current vascular pharmacology 15 (2), 115-122, 2017 | 459 | 2017 |
| Nanoparticles and cancer therapy: a concise review with emphasis on dendrimers DJ Bharali, M Khalil, M Gurbuz, TM Simone, SA Mousa International journal of nanomedicine, 1-7, 2009 | 457 | 2009 |
| Introducing nanochemoprevention as a novel approach for cancer control: proof of principle with green tea polyphenol epigallocatechin-3-gallate IA Siddiqui, VM Adhami, DJ Bharali, BB Hafeez, M Asim, SI Khwaja, ... Cancer research 69 (5), 1712-1716, 2009 | 423 | 2009 |
| Identification of novel peptide antagonists for GPIIb/IIIa from a conformationally constrained phage peptide library KT O'Neil, RH Hoess, SA Jackson, NS Ramachandran, SA Mousa, ... Proteins: Structure, Function, and Bioinformatics 14 (4), 509-515, 1992 | 418 | 1992 |
| Oxidized low-density lipoprotein as a biomarker of cardiovascular diseases A Trpkovic, I Resanovic, J Stanimirovic, D Radak, SA Mousa, ... Critical reviews in clinical laboratory sciences 52 (2), 70-85, 2015 | 408 | 2015 |
| International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer P Debourdeau, D Farge, M Beckers, C Baglin, RM Bauersachs, B Brenner, ... Journal of Thrombosis and Haemostasis 11 (1), 71-80, 2013 | 394 | 2013 |
| l-Thyroxine vs. 3,5,3′-triiodo-l-thyronine and cell proliferation: activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase HY Lin, M Sun, HY Tang, C Lin, MK Luidens, SA Mousa, S Incerpi, ... American Journal of Physiology-Cell Physiology 296 (5), C980-C991, 2009 | 342 | 2009 |
| Emerging nanomedicines for early cancer detection and improved treatment: current perspective and future promise DJ Bharali, SA Mousa Pharmacology & therapeutics 128 (2), 324-335, 2010 | 327 | 2010 |
| Immobilized platelets support human colon carcinoma cell tethering, rolling, and firm adhesion under dynamic flow conditions OJT McCarty, SA Mousa, PF Bray, K Konstantopoulos Blood, The Journal of the American Society of Hematology 96 (5), 1789-1797, 2000 | 297 | 2000 |
| Proangiogenic action of thyroid hormone is fibroblast growth factor–dependent and is initiated at the cell surface FB Davis, SA Mousa, L O’Connor, S Mohamed, HY Lin, HJ Cao, PJ Davis Circulation research 94 (11), 1500-1506, 2004 | 287 | 2004 |
Dhruba BharaliAssistant Director of Nanotechnology, The Pharmaceutical Research Institute, Albany College ofVerified email at acphs.edu